BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25820214)

  • 1. BRAF V600E mutation is a useful marker for differentiating Rathke's cleft cyst with squamous metaplasia from papillary craniopharyngioma.
    Kim JH; Paulus W; Heim S
    J Neurooncol; 2015 May; 123(1):189-91. PubMed ID: 25820214
    [No Abstract]   [Full Text] [Related]  

  • 2. BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke's cleft cysts.
    Schweizer L; Capper D; Hölsken A; Fahlbusch R; Flitsch J; Buchfelder M; Herold-Mende C; von Deimling A; Buslei R
    Neuropathol Appl Neurobiol; 2015 Oct; 41(6):733-42. PubMed ID: 25442675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological study of Rathke's cleft cysts.
    Ikeda H; Yoshimoto T
    Clin Neuropathol; 2002; 21(2):82-91. PubMed ID: 12005257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rathke's cleft cysts: differentiation from other cystic lesions in the pituitary fossa by use of single-shot fast spin-echo diffusion-weighted MR imaging.
    Kunii N; Abe T; Kawamo M; Tanioka D; Izumiyama H; Moritani T
    Acta Neurochir (Wien); 2007 Aug; 149(8):759-69; discussion 769. PubMed ID: 17594050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas.
    Yoshimoto K; Hatae R; Suzuki SO; Hata N; Kuga D; Akagi Y; Amemiya T; Sangatsuda Y; Mukae N; Mizoguchi M; Iwaki T; Iihara K
    Neuropathology; 2018 Feb; 38(1):3-10. PubMed ID: 28840946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma.
    Brastianos PK; Santagata S
    Eur J Endocrinol; 2016 Apr; 174(4):R139-44. PubMed ID: 26563980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TREM-1 expression in craniopharyngioma and Rathke's cleft cyst: its possible implication for controversial pathology.
    Liu Y; Wang CH; Li DL; Zhang SC; Peng YP; Peng JX; Song Y; Qi ST; Pan J
    Oncotarget; 2016 Aug; 7(31):50564-50574. PubMed ID: 27409178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic Rathke's cleft cyst.
    Vandervliet EJ; Vanhoenacker FM; De Praeter G; Vangeneugden J; Parizel PM
    JBR-BTR; 2009; 92(3):180-1. PubMed ID: 19670588
    [No Abstract]   [Full Text] [Related]  

  • 9. Papillary craniopharyngioma in a 4-year-old girl with BRAF V600E mutation: a case report and review of the literature.
    Borrill R; Cheesman E; Stivaros S; Kamaly-Asl ID; Gnanalingham K; Kilday JP
    Childs Nerv Syst; 2019 Jan; 35(1):169-173. PubMed ID: 30069716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Craniopharyngioma arising in a Rathke's cleft cyst: case report.
    Alomari AK; Kelley BJ; Damisah E; Marks A; Hui P; DiLuna M; Vortmeyer A
    J Neurosurg Pediatr; 2015 Mar; 15(3):250-4. PubMed ID: 25555112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemistry or Molecular Analysis: Which Method Is Better for Subtyping Craniopharyngioma?
    Fukuhara N; Iwata T; Inoshita N; Yoshimoto K; Kitagawa M; Fukuhara H; Tatsushima K; Yamaguchi-Okada M; Takeshita A; Ito J; Takeuchi Y; Yamada S; Nishioka H
    Endocr Pathol; 2021 Jun; 32(2):262-268. PubMed ID: 32965631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Giant suprasellar Rathke's cleft cyst mimicking craniopharyngioma: implications for a spectrum of cystic epithelial lesions of ectodermal origin.
    Choudhry OJ; Choudhry A; Patel SK; Baisre A; Eloy JA; Liu JK
    J Neurol Surg A Cent Eur Neurosurg; 2012 Sep; 73(5):324-9. PubMed ID: 22847066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors.
    Roque A; Odia Y
    CNS Oncol; 2017 Apr; 6(2):95-99. PubMed ID: 28425764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
    Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
    Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic lesions of the pituitary: clinicopathological features distinguishing craniopharyngioma, Rathke's cleft cyst, and arachnoid cyst.
    Shin JL; Asa SL; Woodhouse LJ; Smyth HS; Ezzat S
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3972-82. PubMed ID: 10566636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EpCAM (CD326) is differentially expressed in craniopharyngioma subtypes and Rathke's cleft cysts.
    Thimsen V; Hölsken A; Buchfelder M; Flitsch J; Fahlbusch R; Stefanits H; Losa M; Jones DT; Buslei R
    Sci Rep; 2016 Jul; 6():29731. PubMed ID: 27431859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of symptomatic Rathke's cyst.
    Naik VD; Thakore NR
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23355555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rathke's cleft cyst presenting as bilateral abducens nerve palsy.
    Grover V; Hamrahian AH; Prayson RA; Weil RJ
    Pituitary; 2011 Dec; 14(4):395-9. PubMed ID: 19621262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A giant retroclival Rathke's cleft cyst.
    Chuang CC; Chen YL; Jung SM; Pai PC
    J Clin Neurosci; 2010 Sep; 17(9):1189-91. PubMed ID: 20627584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-metastatic squamous cell carcinoma within a Rathke's cleft cyst.
    O'Neill BT; Segkos K; Kasper EM; Pallotta JA
    Pituitary; 2016 Feb; 19(1):105-9. PubMed ID: 25715776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.